Comar LLC has a new leader as the packaging and medical device company's longtime CEO becomes chairman.
Brian Larkin is the new CEO at the Voorhees, N.J.-based company that has 11 manufacturing and distribution locations as he succeeds Mike Ruggieri, Comar said Sept. 28.
Ruggieri will transition to chairman and will remain on the board of directors.
Ruggieri led Comar for 15 years, a time when the company transitioned from a family-owned operation to now being majority owned by Morgan Stanley Capital Partners.
"Brian is the right leader for Comar," Ruggieri said in a statement. "Brian's extensive background in the health care industry combined with his innate business development skills should help Comar strengthen partnerships, develop strategic alliances, and expand our international sales presence."
Larkin previously was CEO at medical equipment and scientific glassware maker SP Industries and vice president and general manager of Becton Dickinson's U.S. diabetes care business. He also was senior vice president and general manager for LifeCell Corp., and corporate vice president at Integra Lifesciences. He currently serves on the Dynatronics Corp. board.
"This is a unique opportunity to bring a fresh perspective to Comar while maintaining seamless continuity. Mike will remain an integral part of the company, while Brian will bring a new vision and a strong customer lens to all aspects of the business," said Eric Kanter, managing director at Morgan Stanley Capital Partners, in a statement.
On the packaging side, Comar uses injection molding, injection blow molding, extrusion blow molding, injection stretch blow molding. Markets include pharmaceutical, nutraceuticals and supplements, personal care, household, institutional, specialty food and beverage. Markets on the medical side include diagnostics, surgical and drug delivery.